4//SEC Filing
Jeffery Katherine 4
Accession 0001062993-21-012395
CIK 0001835567other
Filed
Dec 6, 7:00 PM ET
Accepted
Dec 7, 5:24 PM ET
Size
8.3 KB
Accession
0001062993-21-012395
Insider Transaction Report
Form 4
Jeffery Katherine
Chief People Officer
Transactions
- Award
Stock Option (Right to Buy)
2021-12-03+44,172→ 44,172 totalExercise: $1.29Exp: 2031-01-26→ Common Stock (44,172 underlying) - Award
Stock Option (Right to Buy)
2021-12-03+279,758→ 279,758 totalExercise: $1.09Exp: 2029-06-26→ Common Stock (279,758 underlying)
Footnotes (4)
- [F1]25% of the shares underlying the option vested or shall vest on June 26, 2020 and an additional 2.0833 and 1/3% of the shares vested or shall vest on the last day of each calendar month thereafter.
- [F2]Received in accordance with the terms of the Business Combination Agreement (the "Business Combination Agreement") dated as of June 21, 2021, by and among Thimble Point Acquisition Corp., Oz Merger Sub, Inc. and Pear Therapeutics (US), Inc. (f/k/a Pear Therapeutics, Inc.) ("Private Pear"), in exchange for an option to acquire 190,000 shares of common stock of Private Pear for $1.60 per share.
- [F3]25% of the shares underlying the option vested or shall vest on January 26, 2022 and an additional 2.0833 and 1/3% of the shares vested or shall vest on the last day of each calendar month thereafter.
- [F4]Received in accordance with the terms of the Business Combination Agreement in exchange for an option to acquire 30,000 shares of common stock of Private Pear for $1.89 per share.
Issuer
Pear Therapeutics, Inc.
CIK 0001835567
Entity typeother
Related Parties
1- filerCIK 0001881043
Filing Metadata
- Form type
- 4
- Filed
- Dec 6, 7:00 PM ET
- Accepted
- Dec 7, 5:24 PM ET
- Size
- 8.3 KB